ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      Acadia Pharmaceuticals Inc
      Acadia Pharmaceuticals Inc
      ACAD
      Market Cap$4.38B
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Acadia Pharmaceuticals IncAcadia Pharmaceuticals Inc19.6-27%4.20.1
      $28.80
      Target Price by Analysts
      14% upsideAcadia Pharmaceuticals Target Price DetailsTarget Price
      $18.95
      Current Fair Value
      25% downside
      Overvalued by 25% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$4.38 Billion
      Enterprise Value$4.22 Billion 
      Dividend Yield$- (-)
      Earnings per Share$1.37 
      Beta0.71
      Outstanding Shares167,827,000
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio19.63
      PEG-97.51
      Price to Sales4.21
      Price to Book Ratio6.32
      Enterprise Value to Revenue4.14
      Enterprise Value to EBIT43.01
      Enterprise Value to Net Income18
      Total Debt to Enterprise0.02
      Debt to Equity0.11
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About Acadia Pharmaceuticals Inc
      CEO: Uli Hacksell 
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×